1. Home
  2. KNRX vs ATNM Comparison

KNRX vs ATNM Comparison

Compare KNRX & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNRX
  • ATNM
  • Stock Information
  • Founded
  • KNRX 2009
  • ATNM 2000
  • Country
  • KNRX Singapore
  • ATNM United States
  • Employees
  • KNRX N/A
  • ATNM N/A
  • Industry
  • KNRX Computer Software: Programming Data Processing
  • ATNM Biotechnology: Pharmaceutical Preparations
  • Sector
  • KNRX Technology
  • ATNM Health Care
  • Exchange
  • KNRX Nasdaq
  • ATNM Nasdaq
  • Market Cap
  • KNRX 49.9M
  • ATNM 50.2M
  • IPO Year
  • KNRX 2025
  • ATNM N/A
  • Fundamental
  • Price
  • KNRX $1.84
  • ATNM $1.32
  • Analyst Decision
  • KNRX
  • ATNM Strong Buy
  • Analyst Count
  • KNRX 0
  • ATNM 2
  • Target Price
  • KNRX N/A
  • ATNM $4.50
  • AVG Volume (30 Days)
  • KNRX 41.7K
  • ATNM 266.8K
  • Earning Date
  • KNRX 11-28-2025
  • ATNM 11-14-2025
  • Dividend Yield
  • KNRX N/A
  • ATNM N/A
  • EPS Growth
  • KNRX N/A
  • ATNM N/A
  • EPS
  • KNRX N/A
  • ATNM N/A
  • Revenue
  • KNRX $10,820,365.00
  • ATNM N/A
  • Revenue This Year
  • KNRX N/A
  • ATNM N/A
  • Revenue Next Year
  • KNRX N/A
  • ATNM N/A
  • P/E Ratio
  • KNRX N/A
  • ATNM N/A
  • Revenue Growth
  • KNRX 24.00
  • ATNM N/A
  • 52 Week Low
  • KNRX $1.25
  • ATNM $1.03
  • 52 Week High
  • KNRX $4.00
  • ATNM $2.41
  • Technical
  • Relative Strength Index (RSI)
  • KNRX N/A
  • ATNM 39.43
  • Support Level
  • KNRX N/A
  • ATNM $1.23
  • Resistance Level
  • KNRX N/A
  • ATNM $1.40
  • Average True Range (ATR)
  • KNRX 0.00
  • ATNM 0.07
  • MACD
  • KNRX 0.00
  • ATNM -0.01
  • Stochastic Oscillator
  • KNRX 0.00
  • ATNM 18.55

About KNRX KNOREX LTD. Class A Ordinary Shares

Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. Its software offers marketers cost-effective solutions and productivity-enhancing capabilities to target audience across various advertising channels and devices through automated processes and algorithms, which is known as programmatic advertising. Its product, Knorex XPOSM, is a self-service enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications. The Company operates in one operating segment, which focuses on platform subscription fee, platform services, managed activations, and professional services.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: